Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
It has been announced that a £90 million 2011-12 package of funding will be given to sixth form colleges for improving buildings and to help meet the demand for additional 16-19 student places which will rise steeply after the compulsory school-leaving age rises to 18 in 2013.
It also makes sixth-form colleges eligible for devolved formula capital for the first time so that funding for maintenance will be given directly to the institution. According to the Government this will give the average sixth-form college an additional £40,000.
David Igoe, chief executive of the Sixth Form Colleges Forum, welcomed the government’s announcement stating that "sixth form colleges have missed out on capital over the last two years and it is very encouraging to see the government redressing this unfairness."
Ironically, this announcement comes at the same time as hostility grows over the government’s proposal to axe EMA. Many commentators argue that this proposal will cause the poorest students to drop out of college and is grossly ‘unfair’.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Senior Associate
Select which mailings you would like to receive from us.
Sign up